期刊的影响因子--文章列表

期刊文章列表
Pearl Moharil，Zhuoya Wan，Apurva Pardeshi，Jiang Li，Haozhe Huang，Zhangyi Luo，Sanjay Rathod，Ziqian Zhang，Yuang Chen，Bei Zhang，Christian A.Fernandez，Jingjing Sun，Song Li（Center for Pharmacogenetics，Department of Pharmaceutical Science，School of Pharmacy，University of Pittsburgh）.Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy：Dual targeting of tumor cells and tumor-associated macrophages[J].Acta Pharmaceutica Sinica B,2022,第3期 Yunhao Wu，Xiu Yu，Yuwei Wang，Yalin Huang，Jiahui Tang，Shuaishuai Gong，Siyu Jiang，Yuanli Xia，Fang Li，Boyang Yu，Yuanyuan Zhang，Junping Kou（State Key Laboratory of Natural Medicines，Jiangsu Key Laboratory of TCM Evaluation and Translational Research，Department of Pharmacology of Chinese Material Medica，School of Traditional Chinese Pharmacy，China Pharmaceutical University）.Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4signaling[J].Acta Pharmaceutica Sinica B,2022,第3期 Meiyue Song¹，Jiaxin Wang²，Youliang Sun³，Junling Pang¹，Xiaona Li¹，Yuan Liu^4,5,6，Yitian Zhou^6,7，Peiran Yang¹，Tianhui Fan¹，Ying Liu¹，Zhaoguo Li⁸，Xianmei Qi¹，Baicun Li¹，Xinri Zhang⁹，Jing Wang¹，Chen Wang^1,4,5（State Key Laboratory of Medical Molecular Biology，Department of Physiology，Institute of Basic Medical Sciences Chinese Academy of Medical Sciences，School of Basic Medicine Peking Union Medical College；Tsinghua-Peking Center for Life Sciences，Department of Biology，College of Medicine，Tsinghua University；School of Pharmaceutical Sciences，Tsinghua University；Department of Pulmonary and Critical Care Medicine，Center of Respiratory Medicine，China-Japan Friendship Hospital；National Clinical Research Center for Respiratory Diseases；Peking Union Medical College，Chinese Academy of Medical Sciences；Peking Union Medical College，MD Program；Department of Respiratory，the Second Affiliated Hospital of Harbin Medical University；Department of Pulmonary and Critical Care Medicine，the First Hospital of Shanxi Medical University）.Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis[J].Acta Pharmaceutica Sinica B,2022,第3期 Sha-Sha Cheng¹，Yuan-Qing Qu²，Jia Wu¹，Guan-Jun Yang^1,3,4，Hao Liu⁵，Wanhe Wang^5,6，Qi Huang²，Feng Chen¹，Guodong Li¹，Chun-Yuen Wong⁷，Vincent Kam Wai Wong²，Dik-Lung Ma⁵，Chung-Hang Leung^1,8（Institute of Chinese Medical Sciences and State Key Laboratory of Quality Research in Chinese Medicine，University of Macau；Dr.Neher's Biophysics Laboratory for Innovative Drug Discovery，State Key Laboratory of Quality Research in Chinese Medicine，Macau University of Science and Technology；State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products，Ningbo University；Laboratory of Biochemistry and Molecular Biology，School of Marine Sciences，Ningbo University；Department of Chemistry，Hong Kong Baptist University；Institute of Medical Research，Northwestern Polytechnical University；Department of Chemistry，City University of Hong Kong；Department of Biomedical Sciences，Faculty of Health Sciences，University of Macau）.Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancer[J].Acta Pharmaceutica Sinica B,2022,第3期 Yang Zhou¹，Fan Tong¹，Weilong Gu¹，Siqin He¹，Xiaotong Yang¹，Jiamei Li¹，Yue-Dong Gao^2,3，Huile Gao¹（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University；Core Technology Facility of Kunming Institute of Zoology，Chinese Academy of Sciences；Chinese Academy of Sciences Territorial Core Facility of Kunming Biological Diversity Regional Center）.Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors[J].Acta Pharmaceutica Sinica B,2022,第3期 Yumei Wang¹，Jia Ke¹，Xianmou Guo¹，Kaijun Gou¹，Zhentao Sang²，Yanbu Wang^1,2，Yan Bian²，Sanming Li¹，Heran Li²（Department of Pharmaceutics，Shenyang Pharmaceutical University；School of Pharmacy，China Medical University）.Chiral mesoporous silica nano-screws as an efficient biomimetic oral drug delivery platform through multiple topological mechanisms[J].Acta Pharmaceutica Sinica B,2022,第3期 Wenhui Tao¹，Dongyang Zhao¹，Guanting Li¹，Lingxiao Li¹，Songhao Li¹，Hao Ye¹，Chutong Tian¹，Yutong Lu¹，Shuying Li²，Yinghua Sun³，Zhonggui He¹，Jin Sun¹（Department of Pharmaceutics，Wuya College of Innovation，Shenyang Pharmaceutical University；Department of Pharmaceutical and Engineering，College of Pharmaceutical and Engineering，Shenyang Pharmaceutical University；Department of Pharmaceutics，College of Pharmacy，Shenyang Pharmaceutical University）.Artificial tumor microenvironment regulated by first hemorrhage for enhanced tumor targeting and then occlusion for synergistic bioactivation of hypoxia-sensitive platesomes[J].Acta Pharmaceutica Sinica B,2022,第3期 Guoping Shu¹，Yueli Tang¹，Mingyuan Yuan¹，Ning Wei¹，Fangyuan Zhang¹，Chunxian Yang¹，Xiaozhong Lan²，Min Chen³，Kexuan Tang¹，Lien Xiang⁴，Zhihua Liao¹（Key Laboratory of Eco-environments in Three Gorges Reservoir Region (Ministry of Education)，Chongqing Engineering Research Centre for Sweet Potato，SWU-TAAHC Medicinal Plant Joint R&D Centre，School of Life Sciences，Southwest University；TAAHC-SWU Medicinal Plant Joint R&D Centre，Xizang Agricultural and Husbandry College；College of Pharmaceutical Sciences，Southwest University；College of Environmental Science and Engineering，China West Normal University）.Molecular insights into AabZIP1-mediated regulation on artemisinin biosynthesis and drought tolerance in Artemisia annua[J].Acta Pharmaceutica Sinica B,2022,第3期 Xiaomeng Gao¹，Jieqiong You¹，Yanling Gong¹，Meng Yuan^1,2，Haiying Zhu¹，Liang Fang³，Hong Zhu^1,4，Meidan Ying^1,4，Qiaojun He^1,2,4，Bo Yang^1,2，Ji Cao^1,2,4（Institute of Pharmacology and Toxicology，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；The Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Department of Biology，Southern University of Science and Technology；Cancer Center of Zhejiang University）.WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit[J].Acta Pharmaceutica Sinica B,2022,第3期 Min-Xia Su¹，Yu-Lian Xu¹，Xiao-Ming Jiang¹，Mu-Yang Huang¹，Le-Le Zhang¹，Luo-Wei Yuan¹，Xiao-Huang Xu¹，Qi Zhu¹，Jian-Li Gao²，Jia-Hong Lu¹，Xiuping Chen¹，Ming-Qing Huang³，Yitao Wang¹，Jin-Jian Lu^1,4（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；School of Pharmaceutical Sciences，Zhejiang Chinese Medical University；College of Pharmacy，Fujian University of Traditional Chinese Medicine；Mo E Frontiers Science Center for Precision Oncology，University of Macau）.c-MYC-mediated TRIB3/P62⁺ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2[J].Acta Pharmaceutica Sinica B,2022,第3期 Fengfeng Li^1,2，Man Jiang^1,2，Minghui Ma^1,2，Xuyang Chen^1,2，Yidan Zhang^1,2，Yixin Zhang^1,2，Yuanyuan Yu^1,2，Yunfeng Cui^1,2，Jiahui Chen^1,2，Hui Zhao^1,2，Zhijie Sun³，Deli Dong^1,2,3（Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China，Key Laboratory of Cardiovascular Research，Ministry of Education)，College of Pharmacy，Harbin Medical University；Translational Medicine Research and Cooperation Center of Northern China，Heilongjiang Academy of Medical Sciences，Harbin Medical University；Department of Pharmacology，China Pharmaceutical University）.Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice[J].Acta Pharmaceutica Sinica B,2022,第3期 Deyan Wu^1,2，Xuehua Zheng³，Runduo Liu²，Zhe Li²，Zan Jiang³，Qian Zhou²，Yue Huang²，Xu-Nian Wu²，Chen Zhang²，Yi-You Huang^1,2，Hai-Bin Luo^1,2（School of Pharmaceutical Sciences，Hainan University；School of Pharmaceutical Sciences，Sun Yat-sen University；School of Pharmaceutical Sciences，Guangzhou Medical University）.Free energy perturbation（FEP）-guided scaffold hopping[J].Acta Pharmaceutica Sinica B,2022,第3期 Kuan Hu¹，Wenyu Wu²，Lin Xie¹，Hao Geng³，Yiding Zhang¹，Masayuki Hanyu¹，Lulu Zhang¹，Yinghuan Liu³，Kotaro Nagatsu¹，Hisashi Suzuki¹，Jialin Guo⁴，Yundong Wu^3,5，Zigang Li^3,6，Feng Wang²，Mingrong Zhang¹（Department of Advanced Nuclear Medicine Sciences，National Institute of Radiological Sciences，National Institutes for Quantum and Radiological Science and Technology；Department of Nuclear Medicin5，Nanjing First Hospital，Nanjing Medical University；State Key Laboratory of Chemical Oncogenomics，the School of Chemical Biology and Biotechnology，Peking University，Shenzhen Graduate School；Rensselaer Polytechnic Institute；Institute of Chemical Biology；Pingshan Translational Medicine Center）.Whole-body PET tracking of a D-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors[J].Acta Pharmaceutica Sinica B,2022,第3期 Cutler T.Lewandowski¹，Megan S.Laham²，Gregory R.J.Thatcher²（Department of Pharmaceutical Sciences，University of Illinois College of Pharmacy；Department of Pharmacology and Toxicology，University of Arizona College of Pharmacy）.Remembering your A, B, C’s：Alzheimer’s disease and ABCA1[J].Acta Pharmaceutica Sinica B,2022,第3期 Qiang Jin¹，Jing Jing Wu²，Yue Wu¹，Hongxin Li¹，Moshe Finel³，Dandan Wang¹，Guangbo Ge¹（Shanghai Frontiers Science Center of TCM Chemical Biology，Institute of Interdisciplinary Integrative Medicine Research，Shanghai University of Traditional Chinese Medicine；Department of Clinical Pharmacology，College of Pharmacy，Dalian Medical University；Division of Pharmaceutical Chemistry and Technology，Faculty of Pharmacy，University of Helsinki）.Optical substrates for drug-metabolizing enzymes：Recent advances and future perspectives[J].Acta Pharmaceutica Sinica B,2022,第3期 Yesi Shi¹，Hongyan Qian²，Peishi Rao²，Dan Mu¹，Yuan Liu²，Gang Liu¹，Zhongning Lin¹（State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine，School of Public Health，Xiamen University；Department of Rheumatology and Clinical Immunology，The First Affiliated Hospital of Xiamen University）.Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases[J].Acta Pharmaceutica Sinica B,2022,第3期 Shiqiao Peng¹，Xiaoying Zhang¹，Lili Yu²，Yanhong Xu³，Yang Zhou⁴，Shengnan Qian¹，Xinyu Cao¹，Xiaotong Ye⁴，Jiajun Yang³，Weiping Jia¹，Jianping Ye^1,5,6（Shanghai Diabetes Institute，Shanghai Jiao Tong University Affiliated Sixth People's Hospital；Department of Immunology，School of Basic Medical Sciences，Xinxiang Medical University；Neurology Department，Shanghai Jiao Tong University Affiliated Sixth People's Hospital；National Demonstration Center for Experimental Fisheries Science Education，College of Fisheries and Life Science，Shanghai Ocean University；Metabolic Disease Research Center，Zhengzhou University Affiliated Zhengzhou Central Hospital；Center for Advanced Medicine，College of Medicine，Zhengzhou University）.NF-κB regulates brown adipocyte function through suppression of ANT2[J].Acta Pharmaceutica Sinica B,2022,第3期 Shuhua Shan¹，Jinping Niu¹，Ruopeng Yin¹，Jiangying Shi¹，Lizhen Zhang²，Caihong Wu¹，Hanqing Li²，Zhuoyu Li^1,2（Institute of Biotechnology，Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education，Shanxi University；School of Life Science，Shanxi University）.Peroxidase from foxtail millet bran exerts anticolorectal cancer activity via targeting cellsurface GRP78 to inactivate STAT3 pathway[J].Acta Pharmaceutica Sinica B,2022,第3期 Chenxue Mao^1,2，Juan Chen^1,2，Ting Zou^1,2，Yuankang Zhou^1,2，Junyan Liu^1,2，Xi Li^1,2，Xiangping Li¹，Min Li³，Pinhua Pan³，Wei Zhuo^1,2，Yang Gao⁴，Shuo Hu⁵，Desheng Xiao⁶，Lin Wu⁷，Zhan Wang⁸，Heng Xu⁹，Wen Yang¹⁰，Yingjie Xu¹⁰，Haihua Xiao¹¹，Kazuhiko Hanada¹²，Wei Zhang^1,2，Honghao Zhou^1,2，Jiye Yin^1,2，Zhaoqian Liu^1,2（Departments of Clinical Pharmacology and Pharmacy，Hunan Key Laboratory of Pharmacogenetics，and National Clinical Research Center for Geriatric Disorders，Xiangya Hospital，Central South University；Institute of Clinical Pharmacology，Engineering Research Center of Applied Technology of Pharmacogenomics，Ministry of Education，Central South University；Department of Respiratory，Xiangya Hospital，Central South University；Department of Thoracic Surgery，Xiangya Hospital，Central South University；Department of Nuclear Medicine，Xiangya Hospital，Central South University；Department of Pathology，Xiangya Hospital，Central South University；Department of Thoracic Medicine，Hunan Cancer Hospital；Department of Medical Oncology，Lung Cancer and Gastrointestinal Unit，Hunan Cancer Hospital；State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University and Collaborative Innovation Center of Biotherapy；Department of Molecular and Cellular Biochemistry，School of Medicine，Shanghai Jiaotong University；Beijing National Laboratory for Molecular Sciences，State Key Laboratory of Polymer Physics and Chemistry，Institute of Chemistry，Chinese Academy of Sciences；Department of Pharmacometrics and Pharmacokinetics Meiji Pharmaceutical University）.Genome-wide analysis identify novel germline genetic variations in ADCY1 influencing platinum-based chemotherapy response in nonsmall cell lung cancer[J].Acta Pharmaceutica Sinica B,2022,第3期 Bo Zhuang^1,2，Ting Chen¹，Yueqi Huang¹，Zhimei Xiao¹，Yiguang Jin¹（Department of Pharmaceutical Sciences，Beijing Institute of Radiation Medicine；Department of Chemical Defense，Institute of NBC Defense）.Chemo-photothermal immunotherapy for eradication of orthotopic tumors and inhibition of metastasis by intratumoral injection of polydopamine versatile hydrogels[J].Acta Pharmaceutica Sinica B,2022,第3期 Jingyi Li^1,2，Yaqi Zhang^2,3，Miaorong Yu²，Aohua Wang^2,3，Yu Qiu^2,3，Weiwei Fan²，Lars Hovgaard⁴，Mingshi Yang⁵，Yiming Li¹，Rui Wang¹，Xiuying Li⁶，Yong Gan^2,3,7（School of Pharmacy，Shanghai University of Traditional Chinese Medicine；State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Oral Formulation Development；Department of Pharmacy，Faculty of Health and Medical Sciences，University of Copenhagen；University of Texas at Dallas；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients，National Institutes for Food and Drug Control）.The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery[J].Acta Pharmaceutica Sinica B,2022,第3期 Han Xiao^1,2，Rui Zhang¹，Xiaobo Fan¹，Xinglu Jiang¹，Mingyuan Zou¹，Xuejiao Yan³，Haiping Hao⁴，Guoqiu Wu^5,6（Medical School，Southeast University；Department of Clinical Laboratory，the Fifth Affiliated Hospital of Sun Yat-sen University；Department of Cardiology，the Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University；State Key Laboratory of Natural Medicines，Key Lab of Drug Metabolism and Pharmacokinetics，China Pharmaceutical University；Center of Clinical Laboratory Medicine，Zhongda Hospital，Southeast University；Jiangsu Provincial Key Laboratory of Critical Care Medicine，Southeast University）.Super-sensitive bifunctional nanoprobe：Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy[J].Acta Pharmaceutica Sinica B,2022,第3期 Canhao Wu^1,2，Qin Xu¹，Huiyuan Wang²，Bin Tu^2,3，Jiaxin Zeng^1,2，Pengfei Zhao^2,4，Mingjie Shi²，Hong Qiu²，Yongzhuo Huang^2,3,5,6（Artemisinin Research Center，First Clinical School，Guangzhou University of Chinese Medicine；State Key Laboratory of Drug Research，Shanghai Institute of Materia Medic1，Chinese Academy of Sciences；Zhongshan Institute for Drug Discovery，SIMM，CAS；Center of Clinical Pharmacology，The Second Affiliated Hospital of Zhejiang University，School of Medicine；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients；Taizhou University，School of Advanced Study，Institute of Natural Medicine and Health Product）.Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles[J].Acta Pharmaceutica Sinica B,2022,第3期 Jiwei Cui^1,2，Yuanxin Xu^1,2，Haiyan Tu^1,2，Huacong Zhao^1,2，Honglan Wang^1,2，Liuqing Di^1,2，Ruoning Wang^1,2（College of Pharmacy，Nanjing University of Chinese Medicine；Jiangsu Provincial TCM Engineering Technology，Research Center of High Efficient Drug Delivery System）.Gather wisdom to overcome barriers：Well-designed nano-drug delivery systems for treating gliomas[J].Acta Pharmaceutica Sinica B,2022,第3期 Fangyu Du¹，Ruolin Cao¹，Lu Chen¹，Jianwen Sun¹，Yajie Shi¹，Yang Fu¹，Bruce D.Hammock²，Zhonghui Zheng³，Zhongbo Liu⁴，Guoliang Chen¹（Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education，School of Pharmaceutical Engineering，Shenyang Pharmaceutical University；Department of Entomology and Nematology and UC Davis Comprehensive Cancer Center，University of California Davis；Shandong Xinhua Pharmaceutical Co.，Ltd.；School of Pharmacy，Shenyang Pharmaceutical University）.Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain[J].Acta Pharmaceutica Sinica B,2022,第3期 Ying Zhang¹，Tao Wang¹，Xiaojun Zhang²，Winnie Deuther-Conrad³，Hualong Fu¹，Mengchao Cui¹，Jinming Zhang²，Peter Brust^3,4，Yiyun Huang⁵，Hongmei Jia¹（Key Laboratory of Radiopharmaceuticals (Beijing Normal University)，Ministry of Education，College of Chemistry，Beijing Normal University；Nuclear Medicine Department，Chinese PLA General Hospital；Helmholtz-Zentrum Dresden-Rossendorf，Institute of Radiopharmaceutical Cancer Research，Department of Neuroradiopharmaceuticals；The Lübeck Institute of Experimental Dermatology，University Medical Center Schleswig-Holstein；PET Center，Department of Radiology and Biomedical Imaging，Yale University School of Medicine）.Discovery and development of brain-penetrant ¹⁸F-labeled radioligands for neuroimaging of the sigma-2 receptors[J].Acta Pharmaceutica Sinica B,2022,第3期 Wei Xie¹，Shuanghuan Liu²，Guanqiao Li³，Huiyan Xu¹，Liyun Zhou¹（Pharmcube (Beijing) Co.，Ltd.；National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Tsinghua Clinical Research Institute (TCRI)，School of Medicine，Tsinghua University）.The evolving treatment paradigm of lung cancer in China[J].Acta Pharmaceutica Sinica B,2022,第3期 Peng Teng¹，Jianfeng Cai²（College of Pharmaceutical Sciences，Zhejiang University；Department of Chemistry，University of South Florida）.Using proteomimetics to switch angiogenic signaling[J].Acta Pharmaceutica Sinica B,2022,第3期首页上一页 7 8 9 10 11 下一页尾页共有12页，转到页

期刊文章列表